Dr. Ala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
751 N Rutledge St
Springfield, IL 62702Phone+1 217-545-8417Fax+1 217-545-1903
Education & Training
- University of MinnesotaResidency, Neurology, 1986 - 1987
- University of MinnesotaResidency, Neurology, 1981 - 1985
- University of Minnesota Medical SchoolClass of 1981
Certifications & Licensure
- IL State Medical License 1999 - 2026
- MN State Medical License 1985 - 2000
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) Start of enrollment: 2013 Mar 01
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 233 citationsDevelopment of Scoring Criteria for the Clock Drawing Task in Alzheimer's DiseaseMario F. Mendez, Thomas Ala, Kara L. Underwood
Journal of the American Geriatrics Society. 1992-11-01 - 14 citationsThe Inability of Older Adults to Recall Their Drugs and Medical ConditionsGaToya Jones, Vajeeha Tabassum, Gregory J. Zarow, Thomas A. Ala
Drugs & Aging. 2015-04-01 - 94 citationsPentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's diseaseThomas A. Ala, L F Hughes, G A Kyrouac, M W Ghobrial, Rodger J. Elble
Journal of Neurology, Neurosurgery, and Psychiatry. 2001-04-01
Press Mentions
- Safety and Efficacy of Edonerpic Maleate for Patients with Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical TrialJuly 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: